National Research Council (U.S.). Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II, & ebrary, Inc. (2011). Risk-characterization framework for decision-making at the food and drug administration. National Academies Press.
Ondo kopiatu da
Kopiatzeak huts egin du
Chicago Style (17th ed.) Zitazioa
National Research Council (U.S.). Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II, eta Inc ebrary. Risk-characterization Framework for Decision-making at the Food and Drug Administration. Washington, DC: National Academies Press, 2011.
Ondo kopiatu da
Kopiatzeak huts egin du
MLA (9th ed.) Zitazioa
National Research Council (U.S.). Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II, eta Inc ebrary. Risk-characterization Framework for Decision-making at the Food and Drug Administration. National Academies Press, 2011.
Ondo kopiatu da
Kopiatzeak huts egin du
Kontuz: berrikusi erreferentzia hauek erabili aurretik.